Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Method and device for extracting vapors in an injection molding machine
Method of sending CTI messages in a communication system
Integrated disk driving module including a stepping motor integrally formed with a base unit
Polymeric structures comprising a siloxane
Method and system of a sensor interface having dynamic automatic gain control
System and method for providing location and access network information support in a network environment
Display screen with an animated graphical user interface
  Randomly Featured Patents
Detection of angular modulated electromagnetic signals
High density plasma CVD reactor with combined inductive and capacitive coupling
Rechargeable flashlight
Apparatus for welding components
Image forming apparatus having toner depletion detection feature
Image pickup device
Method and apparatus for encoding and decoding data using a pseudo-random interleaver
Rollable ridge vent
Equalizer circuitry for mitigating pre-cursor and post-cursor intersymbol interference
Equipment for producing a yarn having loosened fibers and binding threads